Hello, everyone. After a hot snap, the weather seems to have cooled off a bit in the nation's medicine chest. And this allows us to comfortably prop the windows wide open and catch the birds offering a morning symphony. Before we get too carried away, though, here are a few items to help us all get started on another day. Enjoy...
Boehringer-Ingelheim May Buy Actimis For $515M (PharmaTimes)
Lilly's Cymbalta Approved For Fibromyalgia (The Indianapolis Star)
Targacept Edges Closer To Key Test (Raleight News & Observer)
Novartis Withdraws Flu Vaccine Application In Europe (Yahoo/Reuters)
Teva Drug Slows Parkinson's (Bloomberg News)